As of 3:45pm ET
| -0.09 / -2.12%|
The 6 analysts offering 12-month price forecasts for Mesoblast Ltd have a median target of 6.27, with a high estimate of 14.00 and a low estimate of 3.07. The median estimate represents a +51.15% increase from the last price of 4.15.
The current consensus among 8 polled investment analysts is to Buy stock in Mesoblast Ltd. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.